RxDoctor Payments Data

Eric Root, DO

Family Medicine · Kanab, UTNPI 1528445202

Payments from drug & device makers

$909in general payments, 2019–2025

Across 53 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$430
  • Lilly USA, LLC$114
  • Merck$72
  • Novo Nordisk$54
  • Boehringer Ingelheim$44
  • Pfizer$37
  • plus $158 from 7 others

What the payments were for

  • Food & beverage$909100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$909 in reported general payments places this provider in the 60th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$151,646
Medicare patients
596
Services billed
2,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$93,320
JardianceEmpagliflozin48$55,044
TrulicityDulaglutide22$28,727
XareltoRivaroxaban34$28,242
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,085
JanuviaSitagliptin Phosphate24$14,419
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog31$12,266
Bydureon BciseExenatide Microspheres13$10,792
GlyxambiEmpagliflozin/Linagliptin13$6,611
Spiriva RespimatTiotropium Bromide12$6,310
Fluticasone-SalmeterolFluticasone Propion/Salmeterol37$5,003
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$3,544
SymbicortBudesonide/Formoterol Fumarate14$3,161
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen95$3,046
Albuterol Sulfate HfaAlbuterol Sulfate83$2,649

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$93,320110 claims
Boehringer IngelheimJardiance, Glyxambi, Spiriva Respimat$44$67,96473 claims
Lilly USA, LLCTrulicity$114$28,72722 claims
MerckJanuvia$72$14,41924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 928 family medicine providers in Utah.

Other family medicine in Kanab

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →